Category: Medicine and Healthcare
Innovation grants from the biotechnology creators of sustained acoustic medicine (sam®) will advance recipients’ careers in biomedical engineering and sports medicine.
Dr. Ralph Ortiz will present findings on the use of the (sam®) wearable ultrasound unit, which is proven to be effective for treating the challenging condition without invasive surgery or potentially addictive opioid-based medications.
The sam® wearable ultrasound biotechnology is purpose-built to treat the most common athletic injuries, accelerating soft tissue healing and reducing the need for surgery or pain medication.
The developers of sustained acoustic medicine for soft tissue healing will demonstrate its technology for the world’s leading orthopedic surgeons and other medical specialists.
Nearly half of all active-duty Army personnel suffer injuries that sideline them for weeks of service to the country and cost the U.S. billions of dollars. The sam® wearable ultrasound unit can help military personnel return to service by speeding soft tissue healing.
Study shows treatment with low-intensity, continuous ultrasound reduced patients’ pain and need for pain medication.
The science-based magazine cites sustained acoustic medicine as a noteworthy innovation for its ability to promote soft tissue healing anywhere, without restrictions of surgery or injections.
Developer of the sam wearable ultrasound technology launches a unique opportunity for students and healthcare professionals to support costs of education or research.
Sustained acoustic medicine technology from ZetrOZ Systems eliminates veteran’s severe knee pain without surgery or pain medications.
Claudia McCoy, an Ironman and USAT Certified Triathlon Coach, says the sam® long duration ultrasound unit improves her recovery from training and speeds injury healing.
Makers of the sam® wearable ultrasound unit demonstrate how its devices promote injury healing and complement orthopedic surgery procedures.
Creators of sustained acoustic medicine technology will instruct orthopedic surgeons, sports medicine physicians, physical therapists, and other practitioners in using the sam® X1 ultrasound treatment device.
Presentations at long-running, prestigious meeting will focus on effectiveness of sustained acoustic medicine in soft tissue healing.
Clinical education director Dr. Rajiv Mallipudi will present on sam® research and treatment protocols in a program for members of The Orthobiologic Institute.
Agency’s decision signifies that ZetrOZ’s sustained acoustic medicine technology is safe and effective for promoting injury healing in wider range of medical conditions.
At the 2023 annual meeting of military orthopedic surgeons, sam®, or sustained acoustic medicine, technology will showcase its unique ability to accelerate soft tissue healing for the injured warrior.
A new study shows the combination of sustained acoustic medicine and platelet-rich plasma provides better outcomes, reinforcing clinical research on the efficacy of long-duration ultrasound.
Sustained acoustic medicine provides proven soft tissue healing via ZetrOZ's patented wearable ultrasound unit.
Attending PHATS since 2014, this year, ZetrOZ showcased sam® X1 and 2.0 to educate attendees on the benefits of sustained acoustic medicine for hockey professionals.
Sustained acoustic medicine delivered by wearable ultrasound device and topical diclofenac patch reduced patients' pain and improved clinical outcomes beyond traditional patient care.
Displayed the advantages of the sam X1 device as a faster way for patients to repair and recover from soft-tissue injuries before returning to work or play.
New study shows sports medicine providers conclude sustained acoustic medicine speeds injury healing and reduces need for pain medication
Studies show hamstring and UCL injuries are most common in opening weeks, and sustained acoustic medicine is effective treatment for those soft-tissue injuries.
Clinical investigator and regenerative medicine pioneer Don Buford, MD, is leading the charge to bring the latest advances in mechanobiology and regenerative medicine to 32.5 million knee arthritis sufferers across the United States in a National Institutes of Health-funded study aimed at reducing opioids and surgery.
CEO George K. Lewis to make a presentation on sustained acoustic medicine and review the sam technology at the healthcare conference.
The sam® breakthrough technology accelerates athletes' soft tissue healing and recovery time through long-duration ultrasound treatment
The long-duration soft-tissue repair ultrasound device provides healthcare professionals with another proven method of accelerating and enhancing healing.
Sustained acoustic medicine brings relief to professional and collegiate tennis players by promoting soft tissue healing.
The Interventional Orthobiologics Foundation Conference is one of the largest gatherings of orthopedic and interventional pain specialists in the United States with a focus on innovation
The conference provides continuing education and facilitates communication among interested sports medicine professionals.
Creator of wearable sustained acoustic medicine technology to educate clinicians on device's effectiveness in soft tissue healing and regenerative medicine treatment.
The sam®x1 is an effective tool for treating acute musculoskeletal injuries and the first wireless long-duration ultrasound system that is FDA-cleared for prescription home use.
The Ambassador Program seeks athletic trainers and social media influencers, amateurs and professionals alike, to promote the proven real-world benefits of sustained acoustic medicine.
The device's ease of use permits players to wear sam® for long periods discreetly, allowing athletes to attend class while maintaining 100% treatment compliance during recovery.
The lunch and lecture provided scientific updates on sustained acoustic medicine research in sports medicine, significant product innovations, and the new 2023 Player Performance Package (PPP).
The sam®x1 wireless sustained acoustic medicine device helps sports and regenerative medicine providers return their patients to everyday activities.
The specialized ultrasound treatment is now available to medical professionals across the United States.
Board-certified physicians use the ZetrOZ Systems sustained acoustic medicine device for injury healing and pain relief without invasive surgery or potentially addictive and dangerous medications.
First-year graduate students at Merrimack College taking Therapeutic Modalities will learn about the effects and benefits of long-duration, sustained acoustic medicine (sam®) on soft-tissue healing.
ZetrOZ's sam®️ technology promotes soft tissue healing, helping patients return to work sooner and preventing more severe injuries; the only FDA-cleared home-use multi-hour ultrasound stimulator.
ZetrOZ Systems will showcase its sustained acoustic medicine (sam®) technology, a non-invasive, non-systemic treatment option for soft-tissue injuries experienced in the workplace and beyond. The companies' partnerships with self-insured and insurance providers has expanded access to millions of lives in America.
The wireless, long-duration, continuous, ultrasound, patch-based stimulator delivers 33 times more treatment than pulsed ultrasound devices and is authorized by the FDA for prescription home use in the United States of America.
The wearable sustained acoustic medicine (sam®) treatment has been effectively utilized by sports medicine doctors, athletes and beyond to help rapidly treat tendon, ligament and other soft-tissue injuries.
A sam® regimen prioritizes healing beyond the pain to emphasize the importance of returning patients fully back to health to minimize the risk of chronic, recurring injuries.
New clinical research sheds light on the use of sam®, a medical ultrasound device for prescription home use, for pain mitigation in soft tissue injuries.
At a recent conference of professional hockey trainers, ZetrOZ Systems, a leading innovator and inventor of sustained acoustic medicine (sam®) for soft tissue injury healing, presented results of studies indicating the medical device is highly effective at treating the types of injuries hockey players frequently experience.
sam® by Zetroz Systems utilizes high-frequency, low-intensity continuous ultrasound to facilitate the healing of injured musculoskeletal tissue in the home of the patient.
Effective management of a company's intellectual property can create significant advantages, crucial in today's competitive health technology marketplace.
Creator of sustained acoustic medicine soft tissue healing device reports that even FDA-cleared devices backed by body of research and millions of successful treatments still face hurdles.